Weekly doxorubicinversus doxorubicin every 3 weeks in cyclophosphamide, doxorubicin, and cisplatin chemotherapy for non-small cell lung cancer
Year: 1989
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Cancer
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: National Cancer Institute
Award: G1004735096
OpenAlex ID: W2083702415
